Bruce F Wesson is Director of ACURA PHARMACEUTICALS, INC. Currently has a direct ownership of 829,548 shares of ACUR, which is worth approximately $0. The most recent transaction as insider was on Jan 02, 2024, when has been sold 37,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 830K
0% 3M change
4.73% 12M change
Total Value Held $0

BRUCE F WESSON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2024
BUY
Exercise of conversion of derivative security
-
37,500 Added 4.33%
829,548 Common Stock
Jan 03 2023
BUY
Exercise of conversion of derivative security
-
66,666 Added 7.76%
792,048 Common Stock
Jan 03 2022
BUY
Exercise of conversion of derivative security
-
66,666 Added 8.42%
725,382 Common Stock
Jan 04 2021
BUY
Exercise of conversion of derivative security
-
54,790 Added 7.68%
658,716 Common Stock
BFW

Bruce F Wesson

Director
Palatine, IL

Track Institutional and Insider Activities on ACUR

Follow ACURA PHARMACEUTICALS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACUR shares.

Notify only if

Insider Trading

Get notified when an Acura Pharmaceuticals, Inc insider buys or sells ACUR shares.

Notify only if

News

Receive news related to ACURA PHARMACEUTICALS, INC

Track Activities on ACUR